Advertisement

Heart Failure Reviews

, Volume 17, Issue 4–5, pp 581–588 | Cite as

Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management

  • Khalil Murad
  • Dalane W. Kitzman
Article

Abstract

Heart failure (HF) in the elderly is a major public health problem, and its prevalence is rising. Outcomes of HF in the elderly have not changed in the past 2 decades despite the introduction of novel HF therapies. This may be due to the combined impact of multiple comorbidities and frailty. The majority of elderly patients with HF are frail with multiple comorbidities. These comorbidities, along with frailty, contribute to the poor outcome of HF in the elderly and pose independent management challenges. More research is needed to better understand the interaction between frailty and multiple comorbidities and the mechanisms by which they impact HF and its management; develop prognostic tools that incorporate frailty and multiple comorbidities and provide more accurate prediction of outcomes; test available treatments in typical elderly patients; and develop and test novel interventions that directly address the adverse impact of multiple comorbidities and frailty.

Keywords

Aging Chronic diseases Rehospitalization Outcomes 

Notes

Acknowledgments

The Funding sources N.I.H. 5T32HL087730: Training Grant in Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke and N.I.H. R37AG18915; The Claude D. Pepper Older Americans Independence Center of Wake Forest University N.I.H. P30AG21332.

Conflicts of interest

Khalil Murad, MD: None. Dalane W Kitzman, MD: Served as consultant for and/or received grant support from Synvista (>$10K), Bristol-Meyers-Squibb (>$10K), Novartis (>$10K), Boston Scientific (>$10K), Relypsa (>$10K), Forest Laboratories, and Med.

References

  1. 1.
    Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics—2011 update: a report from the American Heart Association. CirculationGoogle Scholar
  2. 2.
    Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355(3):251–259PubMedCrossRefGoogle Scholar
  3. 3.
    Jugdutt BI (2010) Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. doi: 10.1007/s10741-010-9164-8
  4. 4.
    Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP (2002) Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288(17):2144–2150PubMedCrossRefGoogle Scholar
  5. 5.
    Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347(18):1397–1402PubMedCrossRefGoogle Scholar
  6. 6.
    Krumholz H, Parent E, Tu N, Vaccarino V, Wang Y, Radford M, Hennen J (1997) Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 157(1):99–104PubMedCrossRefGoogle Scholar
  7. 7.
    Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360(14):1418–1428PubMedCrossRefGoogle Scholar
  8. 8.
    Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456–2467PubMedCrossRefGoogle Scholar
  9. 9.
    Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet 362(9386):777–781PubMedCrossRefGoogle Scholar
  10. 10.
    Kitzman DW, Hundley WG, Brubaker PH, Morgan TM, Moore JB, Stewart KP, Little WC (2010) A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. Circ Heart Fail 3(4):477–485PubMedCrossRefGoogle Scholar
  11. 11.
    Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM (2010) Telemonitoring in patients with heart failure. N Engl J Med 363(24):2301–2309. doi: 10.1056/NEJMoa1010029 PubMedCrossRefGoogle Scholar
  12. 12.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156PubMedCrossRefGoogle Scholar
  13. 13.
    Morley JE (2001) Anorexia, sarcopenia, and aging. Nutrition 17(7–8):660–663PubMedCrossRefGoogle Scholar
  14. 14.
    Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP (2001) Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 56(3):M158–M166PubMedCrossRefGoogle Scholar
  15. 15.
    Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB (2005) Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc 53(8):1321–1330PubMedCrossRefGoogle Scholar
  16. 16.
    Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162(20):2333–2341PubMedCrossRefGoogle Scholar
  17. 17.
    Leng SX, Xue QL, Tian J, Walston JD, Fried LP (2007) Inflammation and frailty in older women. J Am Geriatr Soc 55(6):864–871PubMedCrossRefGoogle Scholar
  18. 18.
    Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM (2010) Vitamin D deficiency and frailty in older Americans. J Intern Med 268(2):171–180PubMedCrossRefGoogle Scholar
  19. 19.
    Varadhan R, Chaves PH, Lipsitz LA, Stein PK, Tian J, Windham BG, Berger RD, Fried LP (2009) Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices. J Gerontol A Biol Sci Med Sci 64(6):682–687PubMedCrossRefGoogle Scholar
  20. 20.
    Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, Liu Y, Hoffmann U, Bauer DC, Newman AB, Kritchevsky SB, Harris TB, Butler J (2010) Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol 55(19):2129–2137PubMedCrossRefGoogle Scholar
  21. 21.
    Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM (2008) The association between vitamin D and inflammation with the 6-min walk and frailty in patients with heart failure. J Am Geriatr Soc 56(3):454–461PubMedCrossRefGoogle Scholar
  22. 22.
    Cacciatore F, Abete P, Mazzella F, Viati L, Della Morte D, D’Ambrosio D, Gargiulo G, Testa G, Santis D, Galizia G, Ferrara N, Rengo F (2005) Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest 35(12):723–730PubMedCrossRefGoogle Scholar
  23. 23.
    Pulignano G, Del Sindaco D, Di Lenarda A, Tarantini L, Cioffi G, Gregori D, Tinti MD, Monzo L, Minardi G (2010) Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med (Hagerstown) 11(10):739–747CrossRefGoogle Scholar
  24. 24.
    Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799PubMedCrossRefGoogle Scholar
  25. 25.
    von Haehling S, Lainscak M, Springer J, Anker SD (2009) Cardiac cachexia: a systematic overview. Pharmacol Ther 121(3):227–252CrossRefGoogle Scholar
  26. 26.
    Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349(9058):1050–1053PubMedCrossRefGoogle Scholar
  27. 27.
    Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the I-PRESERVE Trial. Circ Heart FailGoogle Scholar
  28. 28.
    Habbu A, Lakkis NM, Dokainish H (2006) The obesity paradox: fact or fiction? Am J Cardiol 98(7):944–948PubMedCrossRefGoogle Scholar
  29. 29.
    Shea MK, Houston DK, Nicklas BJ, Messier SP, Davis CC, Miller ME, Harris TB, Kitzman DW, Kennedy K, Kritchevsky SB (2010) The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT Study. J Gerontol A Biol Sci Med Sci 65(5):519–525PubMedCrossRefGoogle Scholar
  30. 30.
    Feinstein AR, Landis JR (1976) The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. J Chronic Dis 29(4):277–284PubMedCrossRefGoogle Scholar
  31. 31.
    Guralnik JM (1996) Assessing the impact of comorbidity in the older population. Ann Epidemiol 6(5):376–380PubMedCrossRefGoogle Scholar
  32. 32.
    Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269–2276PubMedCrossRefGoogle Scholar
  33. 33.
    Dahlström U (2005) Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 7(3):309–316PubMedCrossRefGoogle Scholar
  34. 34.
    Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7):1226–1233PubMedCrossRefGoogle Scholar
  35. 35.
    Muzzarelli S, Leibundgut G, Maeder MT, Rickli H, Handschin R, Gutmann M, Jeker U, Buser P, Pfisterer M, Brunner-La Rocca HP (2010) Predictors of early readmission or death in elderly patients with heart failure. Am Heart J 160(2):308–314PubMedCrossRefGoogle Scholar
  36. 36.
    Wong CH, Weiss D, Sourial N, Karunananthan S, Quail JM, Wolfson C, Bergman H (2010) Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study. Aging Clin Exp Res 22(1):54–62PubMedGoogle Scholar
  37. 37.
    Morley JE, Haren MT, Rolland Y, Kim MJ (2006) Frailty. Med Clin North Am 90(5):837–847PubMedCrossRefGoogle Scholar
  38. 38.
    Weiss CO (2010) Frailty and chronic diseases in older adults. Clin Geriatr Med 27(1):39–52CrossRefGoogle Scholar
  39. 39.
    Kitzman DW, Rich MW (2010) Age disparities in heart failure research. JAMA 304(17):1950–1951PubMedCrossRefGoogle Scholar
  40. 40.
    O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14):1439–1450PubMedCrossRefGoogle Scholar
  41. 41.
    Ridda I, Lindley R, MacIntyre RC (2008) The challenges of clinical trials in the exclusion zone: the case of the frail elderly. Australas J Ageing 27(2):61–66PubMedCrossRefGoogle Scholar
  42. 42.
    Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP (2009) BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 301(4):383–392PubMedCrossRefGoogle Scholar
  43. 43.
    Fuat A, Hungin AP, Murphy JJ (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 326(7382):196PubMedCrossRefGoogle Scholar
  44. 44.
    Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):e391–e479PubMedCrossRefGoogle Scholar
  45. 45.
    Pardaens K, Van Cleemput J, Vanhaecke J, Fagard RH (1997) Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart 78(6):564–568PubMedGoogle Scholar
  46. 46.
    Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119(23):3028–3035PubMedCrossRefGoogle Scholar
  47. 47.
    Mockler M, O’Loughlin C, Murphy N, Ryder M, Conlon C, McDonald KM, Ledwidge MT (2009) Causes and consequences of nonpersistence with heart failure medication. Am J Cardiol 103(6):834–838PubMedCrossRefGoogle Scholar
  48. 48.
    Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366(9502):2005–2011PubMedCrossRefGoogle Scholar
  49. 49.
    Fonarow G, Heywood J, Heidenreich P, Lopatin M, Yancy C, Investigators ASACa (2007) Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from acute decompensated heart failure national registry (ADHERE). Am Heart J 153(6):1021–1028PubMedCrossRefGoogle Scholar
  50. 50.
    Levy W, Mozaffarian D, Linker D, Sutradhar S, Anker S, Cropp A, Anand I, Maggioni A, Burton P, Sullivan M, Pitt B, Poole-Wilson P, Mann D, Packer M (2006) The seattle heart failure model: prediction of survival in heart failure. Circulation 113(11):1424–1433PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Epidemiology and Prevention, Division of Public Health SciencesWake Forest University School of MedicineWinston-SalemUSA
  2. 2.Section of General Internal Medicine, Department of Internal MedicineWake Forest University School of MedicineWinston-SalemUSA
  3. 3.Cardiology Section, Department of Internal MedicineWake Forest University School of MedicineWinston-SalemUSA

Personalised recommendations